Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach

Area of Science:

• Cardiology
• Pharmacology
• Allergy and Immunology

Background:

• Clopidogrel is a vital antiplatelet medication for cardiovascular disease patients, particularly after coronary stent implantation.
• Hypersensitivity reactions to clopidogrel shortly after stenting pose a significant clinical challenge.
• Managing these allergic reactions is crucial due to clopidogrel's widespread use in coronary artery disease.

Purpose of the Study:

• To review treatment options for clopidogrel hypersensitivity in patients undergoing coronary stenting.
• To highlight a successful "treating-through" approach for managing clopidogrel allergy without discontinuation.

Main Methods:

• Review of existing literature on clopidogrel hypersensitivity management.
• Description of a clinical institutional approach for managing patients with clopidogrel allergy.
• Emphasis on strategies to continue clopidogrel therapy despite allergic reactions.

Main Results:

• Clopidogrel hypersensitivity can be effectively managed without interrupting essential antiplatelet therapy.
• The "treating-through" strategy enables continued clopidogrel use in allergic patients.
• Successful management ensures ongoing protection against thrombotic events post-stenting.

Conclusions:

• Awareness of management options for clopidogrel hypersensitivity is essential.
• The "treating-through" approach offers a viable strategy to maintain clopidogrel therapy.
• Continued clopidogrel use is feasible and beneficial for cardiovascular patients experiencing allergic reactions.